Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.27
|
1.32
|
1.26
|
1.26
|
1.31
|
1.31
|
|
|
6 272.13
|
45.00
|
1.25
|
1.35
|
1.31
|
1.22
|
1.32
|
1.23
|
|
|
25 859.71
|
123.00
|
1.28
|
1.34
|
1.34
|
1.29
|
1.34
|
1.315
|
|
|
8 211.19
|
27.00
|
1.24
|
1.29
|
1.31
|
1.27
|
1.31
|
1.27
|
|
|
12 322.53
|
75.00
|
1.28
|
1.34
|
1.30
|
1.26
|
1.32
|
1.32
|
|
|
1 641.41
|
26.00
|
1.21
|
1.31
|
1.30
|
1.21
|
1.30
|
1.27
|
|
|
4 861.12
|
28.00
|
1.28
|
1.35
|
1.31
|
1.28
|
1.325
|
1.325
|
|
|
23 542.80
|
69.00
|
1.30
|
1.39
|
1.36
|
1.32
|
1.38
|
1.32
|
|
|
11 193.94
|
79.00
|
1.30
|
1.37
|
1.25
|
1.25
|
1.35
|
1.331
|
|
|
6 158.36
|
55.00
|
1.26
|
1.39
|
1.33
|
1.23
|
1.35
|
1.27
|
|
|
17 078.29
|
71.00
|
Femasys Inc. operates as a biomedical company. The Company researches, develops, and manufactures novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. Femasys serves customers worldwide.